Related Experiment Videos
Cesarean section in a patient with a mitral valve prosthesis
Israel Journal of Medical Sciences
|September 1, 1975
Summary
Pregnancy with a Starr-Edwards mitral valve prosthesis is achievable. A successful cesarean section was performed after switching from warfarin sodium to dipyridamole therapy during pregnancy.
Area of Science:
- Cardiology
- Obstetrics
- Cardiovascular Surgery
Background:
- Rheumatic heart disease poses significant risks during pregnancy.
- Management of anticoagulation in pregnant patients with mechanical heart valve prostheses is complex.
- Starr-Edwards mitral valve prostheses require careful anticoagulation management.
Observation:
- A 24-year-old pregnant woman with rheumatic heart disease and a Starr-Edwards mitral valve prosthesis was managed during her pregnancy.
- Warfarin sodium therapy was discontinued at 33 weeks gestation.
- Dipyridamole therapy was initiated as an alternative anticoagulation regimen.
Findings:
- The patient successfully completed her pregnancy.
- A cesarean section was performed successfully.
- The dipyridamole regimen facilitated a positive pregnancy outcome in this high-risk patient.
Implications:
- This case demonstrates the feasibility of successful pregnancy and delivery in women with mechanical mitral valve prostheses.
- The warfarin sodium to dipyridamole switch regimen appears safe and effective for managing anticoagulation during pregnancy.
- This approach may improve maternal and fetal outcomes in patients with rheumatic heart disease and prosthetic valves.